Related Experiment Video

Updated: Dec 13, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.6K

NKp30 - A prospective target for new cancer immunotherapy strategies

Pedro F Pinheiro1, Gonçalo C Justino1, M Matilde Marques1,2

  • 1Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.

British Journal of Pharmacology
|August 2, 2020
PubMed

Insights

Natural killer (NK) cells use the NKp30 receptor to identify and eliminate tumor cells. Understanding NKp30’s structure is key for developing new immunotherapies targeting cancer.

Area of Science:

  • Immunology and Molecular Biology
  • Structural Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial components of the innate immune system, mediating immunosurveillance.
  • The NKp30 receptor on NK cells plays a vital role in recognizing tumor cells and initiating cytotoxic responses.
  • NKp30 activation involves ligand binding, leading to the release of cytotoxic mediators like perforins and granzymes.

Purpose of the Study:

  • To present the structural details of the NKp30 receptor, focusing on its ligand-binding site.
  • To review ligand-induced structural changes in NKp30 and their correlation with binding affinity.
  • To explore the implications of NKp30 structural dynamics in disease progression and its potential in immunotherapy.

Main Methods:

  • Structural analysis of the NKp30 receptor.
  • Review of experimental data on NKp30 structure-binding affinity relationships.
  • Examination of NKp30's role in cancer and potential therapeutic applications, including CAR-T therapy.

Main Results:

  • Detailed structural insights into the NKp30 ligand-binding site and induced conformational changes.
  • Correlation between NKp30 structural alterations and binding affinity for ligands like B7-H6.
  • Review of NKp30's involvement in disease progression and its therapeutic potential in immunotherapy.

Conclusions:

  • The structural characteristics of NKp30 are critical for its function in immunosurveillance and immune response.
  • Understanding NKp30 structure-ligand interactions provides a foundation for designing targeted immunotherapies.
  • Further research into NKp30 structure is essential for developing novel therapeutic strategies against cancer.
Keywords:
antigen recognition receptors, ligands, cancer, and carcinogenesiscancer pharmacologyimmunopharmacology

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.7K
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins07:20

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Published on: June 14, 2018

12.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
861
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K